Skip to Main Content

Paper Details

Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage.
J Thromb Thrombolysis
21
2022
Author NameAffiliation
Thomas L OrtelDuke University Medical Center
Ian J WelsbyDuke University Medical Center
Ian J WelsbyDuke University Medical Center
  • 1 - 3

Datasets

Release 1.2